Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial

被引:2
|
作者
Lindkvist, Emilie Bundgaard [1 ,2 ]
Laugesen, Christian [1 ,2 ]
Reenberg, Asbjorn Thode [3 ]
Ritschel, Tobias Kasper Skov [3 ]
Svensson, Jannet [1 ,4 ]
Jorgensen, John Bagterp [3 ]
Norgaard, Kirsten [1 ,2 ]
Ranjan, Ajenthen G. G. [1 ,5 ]
机构
[1] Copenhagen Univ Hosp, Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark
[4] Herlev & Gentofte Univ Hosp, Dept Pediat, Herlev, Denmark
[5] Danish Diabet Acad, Odense, Denmark
来源
关键词
type 1 diabetes mellitus; adolescents; dual-hormone; advanced hybrid closed-loop; artificial pancreas; non-linear model predictive control; moderate intensity continuous exercise; ARTIFICIAL PANCREAS; OPEN-LABEL; GLYCEMIC CONTROL; PUMP THERAPY; GLUCOSE; OUTPATIENT; PAIN;
D O I
10.3389/fendo.2023.1073388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo assess the efficacy and safety of a dual-hormone (DH [insulin and glucagon]) closed-loop system compared to a single-hormone (SH [insulin only]) closed-loop system in adolescents with type 1 diabetes. MethodsThis was a 26-hour, two-period, randomized, crossover, inpatient study involving 11 adolescents with type 1 diabetes (nine males [82%], mean +/- SD age 14.8 +/- 1.4 years, diabetes duration 5.7 +/- 2.3 years). Except for the treatment configuration of the DiaCon Artificial Pancreas: DH or SH, experimental visits were identical consisting of: an overnight stay (10:00 pm until 7:30 am), several meals/snacks, and a 45-minute bout of moderate intensity continuous exercise. The primary endpoint was percentage of time spent with sensor glucose values below range (TBR [<3.9 mmol/L]) during closed-loop control over the 26-h period (5:00 pm, day 1 to 7:00 pm, day 2). ResultsOverall, there were no differences between DH and SH for the following glycemic outcomes (median [IQR]): TBR 1.6 [0.0, 2.4] vs. 1.28 [0.16, 3.19]%, p=1.00; time in range (TIR [3.9-10.0 mmol/L]) 68.4 [48.7, 76.8] vs. 75.7 [69.8, 87.1]%, p=0.08; and time above range (TAR [>10.0 mmol/L]) 28.1 [18.1, 49.8] vs. 23.3 [12.3, 27.2]%, p=0.10. Mean ( +/- SD) glucose was higher during DH than SH (8.7 ( +/- 3.2) vs. 8.1 ( +/- 3.0) mmol/L, p<0.001) but coefficient of variation was similar (34.8 ( +/- 6.8) vs. 37.3 ( +/- 8.6)%, p=0.20). The average amount of rescue carbohydrates was similar between DH and SH (6.8 ( +/- 12.3) vs. 9.5 ( +/- 15.4) grams/participant/visit, p=0.78). Overnight, TIR was higher, TAR was lower during the SH visit compared to DH. During and after exercise (4:30 pm until 7 pm) the SH configuration produced higher TIR, but similar TAR and TBR compared to the DH configuration. ConclusionsDH and SH performed similarly in adolescents with type 1 diabetes during a 26-hour inpatient monitoring period involving several metabolic challenges including feeding and exercise. However, during the night and around exercise, the SH configuration outperformed DH.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol
    Kaat Beunen
    Nancy Van Wilder
    Dominique Ballaux
    Gerd Vanhaverbeke
    Youri Taes
    Xavier-Philippe Aers
    Frank Nobels
    Joke Marlier
    Dahae Lee
    Joke Cuypers
    Vanessa Preumont
    Sarah E. Siegelaar
    Rebecca C. Painter
    Annouschka Laenen
    Pieter Gillard
    Chantal Mathieu
    Katrien Benhalima
    [J]. BMC Pregnancy and Childbirth, 23
  • [42] A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System for Postbariatric Hypoglycemia
    Mulla, Christopher M.
    Zavitsanou, Stamatina
    Sanz, Alejandro Jose Laguna
    Pober, David
    Richardson, Lauren
    Walcott, Pamela
    Arora, Ipsa
    Newswanger, Brett
    Cummins, Martin J.
    Prestrelski, Steve J.
    Doyle, Francis J., III
    Dassau, Eyal
    Patti, Mary Elizabeth
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : E1260 - E1271
  • [43] Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes
    Elleri, Daniela
    Allen, Janet M.
    Kumareswaran, Kavita
    Leelarathna, Lalantha
    Nodale, Marianna
    Caldwell, Karen
    Cheng, Peiyao
    Kollman, Craig
    Haidar, Ahmad
    Murphy, Helen R.
    Wilinska, Malgorzata E.
    Acerini, Carlo L.
    Dunger, David B.
    Hovorka, Roman
    [J]. DIABETES CARE, 2013, 36 (04) : 838 - 844
  • [44] The "Glucositter" overnight automated closed loop system for type 1 diabetes: A randomized crossover trial
    Nimri, Revital
    Danne, Thomas
    Kordonouri, Olga
    Atlas, Eran
    Bratina, Natasa
    Biester, Torban
    Avbelj, Magdalena
    Miller, Shahar
    Muller, Ido
    Phillip, Moshe
    Battelino, Tadej
    [J]. PEDIATRIC DIABETES, 2013, 14 (03) : 159 - 167
  • [45] Usability of FlorenceD Closed-Loop System during Overnight Home Use in Adolescents With Type 1 Diabetes
    Allen, Janet M.
    Elleri, Daniela
    Nodale, Marianna
    Gulati, Arti
    Thabit, Hood
    Leelarathna, Lalantha
    Caldwell, Karen
    Wilinska, Malgorzata E.
    O'Sullivan, Esther
    Murphy, Helen R.
    Acerini, Carlo L.
    Dunger, David B.
    Wysocki, Timothy T.
    Hovorka, Roman
    [J]. DIABETES, 2013, 62 : A254 - A254
  • [46] Impact of a Hybrid Closed-Loop Insulin Delivery System on Hypoglycemia Awareness in Individuals with Type 1 Diabetes
    Burckhardt, Marie-Anne
    Dart, Julie
    Smith, Grant J.
    Abraham, Mary B.
    Paramalingam, Nirubasini
    O'Dea, Joanne M.
    de Bock, Martin
    Davis, Elizabeth A.
    Jones, Timothy
    [J]. DIABETES, 2019, 68
  • [47] Clinical evaluation of a closed-loop insulin delivery system on glycaemic control in adults with type 1 diabetes
    Koutsovasilis, A.
    Sotiropoulos, A.
    Pappa, M.
    Kordinas, V.
    Bourikou, M.
    Bletsa, E.
    Bousboulas, S.
    Peppas, T.
    [J]. DIABETOLOGIA, 2019, 62 : S21 - S21
  • [48] Efficacy of the hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysis
    Ferreira, Rafael Oliva Morgado
    Trevisan, Talita
    Pasqualotto, Eric
    Schmidt, Pedro
    Chavez, Matheus Pedrotti
    Watanabe, Janine Midori Figueiredo
    van de Sande-Lee, Simone
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [49] Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
    Brown, S. A.
    Kovatchev, B. P.
    Raghinaru, D.
    Lum, J. W.
    Buckingham, B. A.
    Kudva, Y. C.
    Laffel, L. M.
    Levy, C. J.
    Pinsker, J. E.
    Wadwa, R. P.
    Dassau, E.
    Doyle, F. J., III
    Anderson, S. M.
    Church, M. M.
    Dadlani, V
    Ekhlaspour, L.
    Forlenza, G. P.
    Isganaitis, E.
    Lam, D. W.
    Kollman, C.
    Beck, R. W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1707 - 1717
  • [50] Efficacy and safety of closed-loop control system for type one diabetes in adolescents a meta analysis
    Jabari, Mosleh
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)